Please use this identifier to cite or link to this item:
|Title:||Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1||Authors:||Choquet, Hélène
Hart, Blaine L.
Morrison, Leslie A.
Retta, Saverio Francesco
|Keywords:||1,25-OH2-D3 1,25-dihydroxyvitamin D3; 24-OHC 24(S)-hydroxycholesterol; 25-OH-D3 25-hydroxyvitamin D3; 27-OHC 27-hydroxycholesterol; AA arachidonic acid; Abbreviations CCM Cerebral Cavernous Malformation; BBB blood-brain barrier; CHM common hispanic mutation; CYP cytochrome P450; ECM extracellular matrix; EET epoxyeicosatrienoic acids; ICH intracerebral hemorrhage; LT leukotrienes; MMP matrix metalloproteinase; NVU neurovascular unit; PG prostaglandins; ROS reactive oxygen species; SNP single nucleotide polymorphism; Biochemistry; Physiology (medical)||Issue Date:||2016||Project:||None||Journal:||FREE RADICAL BIOLOGY & MEDICINE||Abstract:||
Familial Cerebral Cavernous Malformation type 1 (CCM1) is an autosomal dominant disease caused by mutations in the Krev Interaction Trapped 1 (KRIT1/CCM1) gene, and characterized by multiple brain lesions. CCM lesions manifest across a range of different phenotypes, including wide differences in lesion number, size and susceptibility to intracerebral hemorrhage (ICH). Oxidative stress plays an important role in cerebrovascular disease pathogenesis, raising the possibility that inter-individual variability in genes related to oxidative stress may contribute to the phenotypic differences observed in CCM1 disease. Here, we investigated whether candidate oxidative stress-related cytochrome P450 (CYP) and matrix metalloproteinase (MMP) genetic markers grouped by superfamilies, families or genes, or analyzed individually influence the severity of CCM1 disease.
|Appears in Collections:||Publications|
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.